552 related articles for article (PubMed ID: 21862702)
1. Mechanisms and genetic determinants regulating sterol absorption, circulating LDL levels, and sterol elimination: implications for classification and disease risk.
Calandra S; Tarugi P; Speedy HE; Dean AF; Bertolini S; Shoulders CC
J Lipid Res; 2011 Nov; 52(11):1885-926. PubMed ID: 21862702
[TBL] [Abstract][Full Text] [Related]
2. Hepatic ABCG5/G8 overexpression reduces apoB-lipoproteins and atherosclerosis when cholesterol absorption is inhibited.
Basso F; Freeman LA; Ko C; Joyce C; Amar MJ; Shamburek RD; Tansey T; Thomas F; Wu J; Paigen B; Remaley AT; Santamarina-Fojo S; Brewer HB
J Lipid Res; 2007 Jan; 48(1):114-26. PubMed ID: 17060690
[TBL] [Abstract][Full Text] [Related]
3. Hepatic ABCG5 and ABCG8 overexpression increases hepatobiliary sterol transport but does not alter aortic atherosclerosis in transgenic mice.
Wu JE; Basso F; Shamburek RD; Amar MJ; Vaisman B; Szakacs G; Joyce C; Tansey T; Freeman L; Paigen BJ; Thomas F; Brewer HB; Santamarina-Fojo S
J Biol Chem; 2004 May; 279(22):22913-25. PubMed ID: 15044450
[TBL] [Abstract][Full Text] [Related]
4. Cholesterol absorption and synthesis related to low density lipoprotein metabolism during varying cholesterol intake in men with different apoE phenotypes.
Gylling H; Miettinen TA
J Lipid Res; 1992 Sep; 33(9):1361-71. PubMed ID: 1402403
[TBL] [Abstract][Full Text] [Related]
5. Hepatic overexpression of idol increases circulating protein convertase subtilisin/kexin type 9 in mice and hamsters via dual mechanisms: sterol regulatory element-binding protein 2 and low-density lipoprotein receptor-dependent pathways.
Sasaki M; Terao Y; Ayaori M; Uto-Kondo H; Iizuka M; Yogo M; Hagisawa K; Takiguchi S; Yakushiji E; Nakaya K; Ogura M; Komatsu T; Ikewaki K
Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1171-8. PubMed ID: 24675665
[TBL] [Abstract][Full Text] [Related]
6. Proprotein convertase subtilisin kexin type 9 promotes intestinal overproduction of triglyceride-rich apolipoprotein B lipoproteins through both low-density lipoprotein receptor-dependent and -independent mechanisms.
Rashid S; Tavori H; Brown PE; Linton MF; He J; Giunzioni I; Fazio S
Circulation; 2014 Jul; 130(5):431-41. PubMed ID: 25070550
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the apolipoprotein E by dietary lipids occurs by transcriptional and post-transcriptional mechanisms.
Srivastava RA
Mol Cell Biochem; 1996 Feb; 155(2):153-62. PubMed ID: 8700160
[TBL] [Abstract][Full Text] [Related]
8. Targeted disruption of the idol gene alters cellular regulation of the low-density lipoprotein receptor by sterols and liver x receptor agonists.
Scotti E; Hong C; Yoshinaga Y; Tu Y; Hu Y; Zelcer N; Boyadjian R; de Jong PJ; Young SG; Fong LG; Tontonoz P
Mol Cell Biol; 2011 May; 31(9):1885-93. PubMed ID: 21343340
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic variability in 4 homozygous familial hypercholesterolemia siblings compound heterozygous for LDLR mutations.
Rabacchi C; Bigazzi F; Puntoni M; Sbrana F; Sampietro T; Tarugi P; Bertolini S; Calandra S
J Clin Lipidol; 2016; 10(4):944-952.e1. PubMed ID: 27578127
[TBL] [Abstract][Full Text] [Related]
10. Threshold Effects of Circulating Angiopoietin-Like 3 Levels on Plasma Lipoproteins.
Fazio S; Minnier J; Shapiro MD; Tsimikas S; Tarugi P; Averna MR; Arca M; Tavori H
J Clin Endocrinol Metab; 2017 Sep; 102(9):3340-3348. PubMed ID: 28633452
[TBL] [Abstract][Full Text] [Related]
11. Genetic demonstration of intestinal NPC1L1 as a major determinant of hepatic cholesterol and blood atherogenic lipoprotein levels.
Xie P; Zhu H; Jia L; Ma Y; Tang W; Wang Y; Xue B; Shi H; Yu L
Atherosclerosis; 2014 Dec; 237(2):609-17. PubMed ID: 25463095
[TBL] [Abstract][Full Text] [Related]
12. Microsomal triglyceride transfer protein -493T variant reduces IDL plus LDL apoB production and the plasma concentration of large LDL particles.
Lundahl B; Skoglund-Andersson C; Caslake M; Bedford D; Stewart P; Hamsten A; Packard CJ; Karpe F
Am J Physiol Endocrinol Metab; 2006 Apr; 290(4):E739-45. PubMed ID: 16291571
[TBL] [Abstract][Full Text] [Related]
13. Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels.
Cohen JC; Pertsemlidis A; Fahmi S; Esmail S; Vega GL; Grundy SM; Hobbs HH
Proc Natl Acad Sci U S A; 2006 Feb; 103(6):1810-5. PubMed ID: 16449388
[TBL] [Abstract][Full Text] [Related]
14. Metabolism and Modification of Apolipoprotein B-Containing Lipoproteins Involved in Dyslipidemia and Atherosclerosis.
Morita SY
Biol Pharm Bull; 2016; 39(1):1-24. PubMed ID: 26725424
[TBL] [Abstract][Full Text] [Related]
15. Targeted depletion of hepatic ACAT2-driven cholesterol esterification reveals a non-biliary route for fecal neutral sterol loss.
Brown JM; Bell TA; Alger HM; Sawyer JK; Smith TL; Kelley K; Shah R; Wilson MD; Davis MA; Lee RG; Graham MJ; Crooke RM; Rudel LL
J Biol Chem; 2008 Apr; 283(16):10522-34. PubMed ID: 18281279
[TBL] [Abstract][Full Text] [Related]
16. A marked and sustained reduction in LDL sterols by diet and cholestyramine in beta-sitosterolemia.
Parsons HG; Jamal R; Baylis B; Dias VC; Roncari D
Clin Invest Med; 1995 Oct; 18(5):389-400. PubMed ID: 8529322
[TBL] [Abstract][Full Text] [Related]
17. Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease.
Ference BA; Kastelein JJP; Ray KK; Ginsberg HN; Chapman MJ; Packard CJ; Laufs U; Oliver-Williams C; Wood AM; Butterworth AS; Di Angelantonio E; Danesh J; Nicholls SJ; Bhatt DL; Sabatine MS; Catapano AL
JAMA; 2019 Jan; 321(4):364-373. PubMed ID: 30694319
[TBL] [Abstract][Full Text] [Related]
18. Update on the molecular biology of dyslipidemias.
Ramasamy I
Clin Chim Acta; 2016 Feb; 454():143-85. PubMed ID: 26546829
[TBL] [Abstract][Full Text] [Related]
19. ABCA1 overexpression in the liver of LDLr-KO mice leads to accumulation of pro-atherogenic lipoproteins and enhanced atherosclerosis.
Joyce CW; Wagner EM; Basso F; Amar MJ; Freeman LA; Shamburek RD; Knapper CL; Syed J; Wu J; Vaisman BL; Fruchart-Najib J; Billings EM; Paigen B; Remaley AT; Santamarina-Fojo S; Brewer HB
J Biol Chem; 2006 Nov; 281(44):33053-65. PubMed ID: 16928680
[TBL] [Abstract][Full Text] [Related]
20. Primary structure comparison of the proposed low density lipoprotein (LDL) receptor binding domain of human and pig apolipoprotein B: implications for LDL-receptor interactions.
Ebert DL; Maeda N; Lowe SW; Hasler-Rapacz J; Rapacz J; Attie AD
J Lipid Res; 1988 Nov; 29(11):1501-9. PubMed ID: 3241126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
